Clinical Trials Logo

Clinical Trial Summary

Idiopathic purpura fulminans by anti-protein S antibody is a very rare but potentially extremely serious entity. The data in the literature are poor with only isolated report boxes and a single series of less than 10 boxes. The creation of a larger series of cases would make it possible to better understand this pathology and to offer assistance in diagnosis and management.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04845113
Study type Observational
Source University Hospital, Montpellier
Contact
Status Completed
Phase
Start date January 1, 2021
Completion date July 31, 2021